Rectify Pharmaceuticals
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
300 Technology Sq Ste 8, Cambridge, Mass...Website
www.rectifypharma.comRevenue
$13.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company based in Cambridge, MA. Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.Explore more
Rectify Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rectify Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Rectify Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Rectify Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Rectify Pharmaceuticals had a recent Job posting/layoffs
Rectify Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Rectify Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Rectify Pharmaceuticals
Check out if Rectify Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Rectify Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Rectify Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Rectify Pharmaceuticals
Compare insights from companies similar to Rectify Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rectify Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rectify Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rectify Pharmaceuticals.
Rectify Pharmaceuticals financials insights
Gather financial insights about Rectify Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$100M
Rectify Pharmaceuticals Tech Stack
A closer look at the technologies used by Rectify Pharmaceuticals
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Rectify Pharmaceuticals News & Media
Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026
Data highlight RTY-406's dual ABCB4/BSEP mechanism and marks the first demonstration of proof of mechanism in a non-human primate model that closely mirrors the human hepatobiliary system Data highlight RTY-406's dual ABCB4/BSEP mechanism and marks the first demonstration of proof of mechanism in a non-human primate model that closely mirrors the human hepatobiliary systemRectify and Boehringer Ingelheim Collaborate to Advance First-in-class Treatments for Chronic Kidney Disease
BOSTON, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, has entered a strategic research and licensing agreement with Boehringer Ingelheim to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions.Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025
Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD)Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a preclinical abstract in a focused oral presentation at the upcoming 62nd European Renal Association (ERA) Congress taking place in Vienna, Austria, and virtually on June 4 – 7, 2025.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Rectify Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rectify Pharmaceuticals is a biotechnology company based in Cambridge, MA. Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.... Read More
